Judicialização de medicamentos no Sistema Único de Saúde (SUS)

Abstract

Introduction: Health is a right of all citizens and a duty of the State, guaranteed through social and economic policies aimed at reducing the risk of disease and other injuries and universal and equal access to actions and services for its promotion, protection and recovery. When services do not comply with public policies regarding access to medication, the path used is judicialization, which generates large expenses. Objective: This study sought to present updated data on the process of judicialization of health, in particular, regarding the medicines offered by the Unified Health System. Methodology: For this, reference data on expenditures on medicines by the Ministry of Health, between the years 2008 to 2021, were analyzed. submitted requests in accordance with the Ministry of Health. The search for information took place in the databases: Conselho Nacional de Justiça – CNJ, sites such as: Scientific Electronic Library Online (Scielo) and Google Scholar. Results and Discussion: Patients who need medications with a certain urgency suffer due to the lengthy judicialization process. In 2008, expenses with medicines totaled 9.1 billion reais and compared to 2019, expenses were 19.8 billion reais, showing us a growing demand. Some of the drugs with the highest number of requests today are: Bevacizumab, Bortezomib, Abiraterone, Desonumab (Prolia®), Temozolamide, Teripratida (Forteo®), Eltrombopag (Revolade®), Rivastigmine Patch, Ustekinumab, Eltrompague Olamine. These drugs are indicated for the treatment of Alzheimer's, Cancer, Cancer glioblastoma multiforme, Multiple myeloma, Osteoporosis, Chronic Immune Thrombocytopenic Purpura (ITP), Psoriasis, Idiopathic Thrombocytopenic Purpura. Conclusion: The costs of the judicialization of health are high and it is necessary for there to be an alignment between the judiciary and managers in order to guarantee the right of the citizen, without, however, generating such high expenses for the system that needs to guarantee medicines that meet the needs comprehensive treatment for each patient.